The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids

The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

留言 (0)

沒有登入
gif